NCT03472599

Brief Summary

Bladder spasms after spinal cord injury (SCI) can result in incontinence, urinary tract infections, kidney damage, trigger dangerous increases in blood pressure and decrease independence and quality of life. The investigators' long-term goal is to develop and provide a "bladder pacemaker" able to restore bladder continence for Veterans with SCI. Electrical stimulation of sensory nerves can stop bladder spasms during a doctor visit. However, this approach has not been tested during long term home use. This proposal will 1) determine how well sensory stimulation reduces incontinence and improves quality of life for Veterans with SCI during 1 year of home use, and 2) produce an effective take home system that can be used by more Veterans and other VAs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 21, 2018

Completed
1.6 years until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

October 25, 2023

Status Verified

October 1, 2023

Enrollment Period

3.9 years

First QC Date

March 5, 2018

Last Update Submit

October 24, 2023

Conditions

Keywords

Neurogenic bladder dysfunctionGenital Nerve StimulationElectrical StimulationUrinary IncontinenceSpinal cord injury

Outcome Measures

Primary Outcomes (1)

  • Incontinence

    The investigators will collect a record of leakage episodes (metric for incontinence) from the specified period.

    Collected over 24 months

Secondary Outcomes (1)

  • Bladder Capacity

    Collected over 24 months

Study Arms (1)

Genital Nerve Stimulation

EXPERIMENTAL

Study participants in this arm will use take-home genital nerve stimulation for 24+ months in order to assess its effectiveness at decreasing urinary incontinence. In order to set effective genital nerve stimulation parameters, study participants will undergo clinical urodynamics every 6 months in which sensitivity to and tolerance of electrical stimulation are assessed.

Other: Genital Nerve Stimulation

Interventions

Genital nerve stimulation activates sensory afferents that travel through the pudendal nerves and enters the spinal cord through the sacral dorsal root ganglia. Inhibitory spinal reflex pathways are activated, causing increased sympathetic outflow through the inferior mesenteric ganglion and hypogastric nerve and also decreased parasympathetic efferent drive through the pelvic nerve, resulting in inhibited bladder contractions.

Genital Nerve Stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Suprasacral neurogenic bladder following spinal cord injury, stroke, or multiple sclerosis
  • Neurologically stable
  • Skeletally mature, over 18 years of age.
  • Reflex bladder contractions confirmed by cystometrogram
  • At least six (6) months post spinal cord injury, stroke, or multiple sclerosis diagnosis
  • Able to understand and comply with study requirements
  • Able to understand and give informed consent

You may not qualify if:

  • Active sepsis
  • Open pressure sores on penis
  • Significant trauma, erosion or stricture of the urethra
  • Pregnancy
  • Individuals who do not speak English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Syracuse VA Medical Center, Syracuse, NY

Syracuse, New York, 13210, United States

Location

Louis Stokes VA Medical Center, Cleveland, OH

Cleveland, Ohio, 44106-1702, United States

Location

Related Publications (2)

  • Bourbeau DJ, Creasey GH, Sidik S, Brose SW, Gustafson KJ. Genital nerve stimulation increases bladder capacity after SCI: A meta-analysis. J Spinal Cord Med. 2018 Jul;41(4):426-434. doi: 10.1080/10790268.2017.1281372. Epub 2017 Feb 15.

    PMID: 28198657BACKGROUND
  • Bourbeau DJ, Gustafson KJ, Brose SW. At-home genital nerve stimulation for individuals with SCI and neurogenic detrusor overactivity: A pilot feasibility study. J Spinal Cord Med. 2019 May;42(3):360-370. doi: 10.1080/10790268.2017.1422881. Epub 2018 Jan 15.

MeSH Terms

Conditions

Urinary IncontinenceSpinal Cord Injuries

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Kenneth J. Gustafson, PhD

    Louis Stokes VA Medical Center, Cleveland, OH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All subjects will take home skin surface electrodes and a simple one-channel electrical stimulators appropriate for extended use set to the stimulus parameters found effective during an initial urodynamics test. Genital nerve stimulation will be applied either continuously or on-demand when individuals turn stimulation on when they feel the onset of bladder leaking.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2018

First Posted

March 21, 2018

Study Start

November 1, 2019

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

October 25, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations